INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

SILVERARC CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001816307)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 179,085 Value ($000) $14,957 Avg Close — Range —
Q3 2024
Shares 167,110 Value ($000) $12,227 Avg Close — Range —
Q2 2024
Shares 192,345 Value ($000) $13,174 Avg Close — Range —
Q1 2024
Shares 34,807 Value ($000) $2,409 Avg Close — Range —
Q4 2023
Shares 80,000 Value ($000) $5,730 Avg Close — Range —
Q3 2023
Shares 208,730 Value ($000) $10,873 Avg Close — Range —
Q2 2023
Shares 198,723 Value ($000) $12,583 Avg Close — Range —
Q1 2023
Shares 125,035 Value ($000) $6,771 Avg Close — Range —
Q4 2022
Shares 140,366 Value ($000) $7,428 Avg Close — Range —
Q3 2022
Shares 136,126 Value ($000) $6,334 Avg Close — Range —
Q2 2022
Shares 313,962 Value ($000) $17,921 Avg Close — Range —
Q1 2022
Shares 308,819 Value ($000) $18,897 Avg Close — Range —
Q4 2021
Shares 195,000 Value ($000) $10,206 Avg Close — Range —
Q3 2021
Shares 101,890 Value ($000) $3,798 Avg Close — Range —
Q2 2021
Shares 113,258 Value ($000) $4,623 Avg Close — Range —
Q1 2021
Shares 130,117 Value ($000) $4,415 Avg Close — Range —
Q4 2020
Shares 200,000 Value ($000) $6,360 Avg Close — Range —